Comparison of ischemic stroke risk in atrial fibrillation patients with or without myocardial infarction: A propensity score matched study

Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure

Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice: a subanalysis of the FANTASIIA registry, a prospective, nationwide, real-world, observational study.

Incidence of incomplete surgical left atrial appendage closure

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

The individual stroke risk in patients with atrial fibrillation

Role of new oral anticoagulants in left atrial occluder device implants

Rapid determination of the anticoagulant effects of dabigatran in whole blood using ROTEM and a thrombin-based trigger

Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database

Use of novel oral anticoagulants in patients with atrial fibrillation and moderate to severe renal dysfunction: findings from a prospective national registry